| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2022 | 2022-05-04 | Future report Set alerts | |
| Q4 2021 | 2022-02-28 | -0.98 | -0.98 |
| Q3 2021 | 2021-11-04 | -1.04 | -1.04 |
| Q2 2021 | 2021-08-05 | 0.00 | 0.00 |
| Q1 2021 | 2021-05-06 | -1.00 | -1.00 |
| Q4 2020 | 2021-02-25 | -1.26 | -1.26 |
| Q3 2020 | 2020-11-09 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-05 | -0.96 | -0.96 |
| Q1 2020 | 2020-05-05 | -0.54 | -0.54 |
| Q4 2019 | 2020-03-02 | -1.26 | -1.26 |
| 2016-05-11 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2016-04-27 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2016-03-11 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-12-15 | Reiterated Rating | Brean Capital | Buy | |
| 2015-11-27 | Reiterated Rating | Leerink Swann | Outperform | $26.00 |
| 2015-11-11 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-11-10 | Initiated Coverage | William Blair | Hold | |
| 2015-11-10 | Lower Price Target | Leerink Swann | Outperform | $27.00 to $26.00 |
| 2015-10-21 | Reiterated Rating | Oppenheimer | Buy | $23.00 |
| 2015-10-21 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | $23.00 |
| 2015-10-06 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-10-01 | Reiterated Rating | Brean Capital | Buy | |
| 2015-09-17 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-08-14 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-08-11 | Reiterated Rating | Leerink Swann | Outperform | |
| 2015-08-11 | Reiterated Rating | William Blair | Hold | |
| 2015-06-15 | Reiterated Rating | Brean Capital | Buy | $2.50 |
| 2015-05-28 | Set Price Target | Brean Capital | Buy | $2.50 |
| 2015-05-12 | Reiterated Rating | Oppenheimer | Outperform | $2.50 |
| 2015-04-29 | Set Price Target | Brean Capital | Positive to Buy | $2.50 |
| 2015-04-21 | Initiated Coverage | Piper Jaffray | Overweight | $2.50 |
| 2015-04-21 | Initiated Coverage | Piper Jaffray Cos. | Overweight | $2.50 |
| 2015-03-11 | Downgrade | William Blair | Outperform to Market Perform | |
| 2015-01-20 | Reiterated Rating | Brean Capital | Buy | |
| 2014-12-29 | Initiated Coverage | Brean Capital | Buy | $2.50 |
| 2014-08-06 | Lower Price Target | Leerink Swann | $3.90 to $3.00 | |
| 2014-08-06 | Lower Price Target | Oppenheimer | Outperform | $5.00 to $2.50 |
| 2014-08-05 | Reiterated Rating | William Blair | Outperform | $5.00 to $3.00 |
| 2014-07-25 | Reiterated Rating | Stifel Nicolaus | Buy | $5.00 to $3.50 |
| 2014-06-06 | Initiated Coverage | R. F. Lafferty | Buy | $3.50 |
| 2014-05-12 | Reiterated Rating | William Blair | Outperform | $6.00 to $5.00 |
| 2014-04-25 | Reiterated Rating | Stifel Nicolaus | Buy | $5.00 |
| 2013-11-14 | Upgrade | Oppenheimer | Market Perform to Outperform | $5.00 |
| 2013-10-29 | Upgrade | Stifel Nicolaus | Hold to Buy | $5.00 |
| 2013-10-28 | Boost Price Target | William Blair | Outperform | $3.00 to $6.00 |
| 2013-03-05 | Initiated | Brinson Patrick | Market Outperform | |
| 2012-12-10 | Downgrade | Oppenheimer | Outperform to Perform | $3 |
| 2011-09-26 | Reiterated | Oppenheimer | Outperform | $9 to $5 |
| 2016-05-11 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2016-04-27 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2016-03-11 | Reiterated Rating | Brean Capital | Buy | $28.00 |
| 2015-12-15 | Reiterated Rating | Brean Capital | Buy | |
| 2015-11-27 | Reiterated Rating | Leerink Swann | Outperform | $26.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In ZGNX 17 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 1.16M |
| BlackRock Institutional Trust Company, N.A. | 0.56M |
| OPPENHEIMER FUNDS INC | 0.14M |
| Broadfin Capital, LLC | 0.13M |
| KNOTT DAVID M | 0.12M |
| BlackRock Investment Management, LLC | 0.11M |
| TEACHERS ADVISORS INC | 98289 |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 69329 |
| TIVERTON ASSET MANAGEMENT LLC | 21885 |
| COWEN GROUP, INC. | 20000 |
| Aperio Group, LLC | 16037 |
| BLACKROCK ADVISORS LLC | 13390 |
| Opus Point Partners Management, LLC | 9725 |
| Kazazian Asset Management, LLC | 7704 |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 343 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| DOMAIN PARTERS VII L P | 7.04% (9923335) | AKAO / CADX / CLVS / ESPR / EVOK / OREX / RGDO / TNDM / ZGNX / |
| Clarus Lifesciences I, L.P. | 6.72% (9482439) | AVNR / GMED / OXFD / ZGNX / |
| WHEELER KURT | 4.24% (5982439) | GMED / ZGNX / |
| Scale Venture Partners II, LP Former 10% Holder | 3.77% (5321546) | ZGNX / |
| PERCEPTIVE ADVISORS LLC | 2.81% (3970357) | ACRX / AEGR / ALDX / BIOD / FOLD / LJPC / PLCC / RPRX / VSAR / ZGNX / |
| FARR STEPHEN J President and COO | 0.64% (902209) | ZGNX / |
| RHOADS ANN D EVP, CFO, Treasurer & Sec. | 0.33% (469980) | EVOK / GMED / IRIX / ZGNX / |
| Shively Richard Scott Chief Commercial Officer | 0.25% (358771) | DEPO / ZGNX / |
| GARNER CAM L | 0.23% (326750) | CADX / EVOK / ZGNX / |
| Halak Brian K | 0.12% (169251) | ACHN / AKAO / ALIM / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / TNDM / VCYT / VNDA / ZGNX / |
| DOVEY BRIAN H | 0.12% (169251) | ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / OTIC / RGDO / TNDM / VCYT / ZGNX / |
| SCHOEMAKER KATHLEEN K | 0.12% (169251) | ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX / |
| BLAIR JAMES C | 0.12% (169251) | ACHN / AKAO / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX / |
| VITULLO NICOLE | 0.12% (169251) | ACHN / AKAO / CADX / CLVS / CPXX / DRNA / DRTX / ESPR / EVOK / MRNS / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX / |
| TREU JESSE I | 0.12% (169251) | ACHN / AKAO / ALDX / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / RGDO / TNDM / VCYT / ZGNX / |
| DP VII ASSOCIATES LP | 0.12% (169251) | AKAO / CADX / CLVS / ESPR / EVOK / OREX / TNDM / ZGNX / |
| HAWLEY ROGER Chief Executive Officer | 0.06% (90575) | CERU / TGEN / ZGNX / |
| Robinson Cynthia Y Chief Development Officer | 0.04% (52746) | ZGNX / |
| MAST ERLE T | 0.02% (24221) | CLVS / RCPT / ZGNX / |
| Haas Ken | 0.01% (19849) | ZGNX / |
| TANNENBAUM RENEE P | 0.01% (10000) | SMED / ZGNX / |
| Domain Partners VI, L.P. | 0.01% (9894) | ALDX / ALIM / CADX / MRNS / OCRX / RGDO / ZGNX / |